Winton Capital »

Abcellera Biologics shares owned by Winton Capital

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Winton Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $442k 56k 7.85
2023-06-30 $111k 17k 6.46

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Solstice Advanced Matls Com Shs (SOLS)
Kla Corp Com New (KLAC)
Masco Corporation (MAS)
Cme (CME)
CSX Corporation (CSX)
Incyte Corporation (INCY)
Entegris (ENTG)
Crowdstrike Hldgs Cl A (CRWD)
Public Storage (PSA)
AES Corporation (AES)
Powell Industries (POWL)

View all positions for Winton Capital

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Two Sigma Investments
TD Waterhouse Canada
Bank of America Corporation
Ubs Global Asset Management Americas
Arrowpoint Asset Management
BlackRock
Susquehanna International
Driehaus Capital Management
Citadel Advisors
Morgan Stanley
UBS Group
Tudor Investment Corporation
Marshall Wace

View all funds holding Abcellera Biologics